Immune System Changes

For the last 4-5 years, Irene Ghobrial, MD, and researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital have focused their efforts on trying to understand mechanisms of disease progression from early precursor conditions, like monoclonal gammopathy of unknown significance (MGUS), to myeloma. In defining what makes someone progress…

Read the full article here

Related Articles